Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand.
Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand.
复制标题
泰国士兵和平民CVD 103-HgR口服霍乱活疫苗不同免疫方案的安全性和免疫原性。
DOI:
10.1093/infdis/165.6.1042
复制
发表时间:
1992
期刊:
影响因子:
--
通讯作者:
Losonsky,G
中科院分区:
文献类型:
--
作者:
Su-Arehawaratana,P;Singharaj,P;Taylor,DN;Hoge,C;Trofa,A;Kuvanont,K;Migasena,S;Pitisuttitham,P;Lim,YL;Losonsky,G
AttenuatedVibrio choleraeoral vaccineCVD 103-HgR was well tolerated by 324 Thai soldiers and civilians. Most receiveda single 5 × 108cfu dose, while 40 each receivedone or two 5 × 109cfu doses. Vibriocidal antibody (the best correlate of immunity) seroconversion was lower in soldiers than civilians (P< .001). Increasing the vaccinedose to 5 × 109cfu raised the geometric mean titer (P< .001).Asecond 5 × 109cfu dose one weeklater did not notably increase seroconversions. Likelihood of seroconversionwas inverselycorrelated with baseline vibriocidal titer (P< .001). CVD 103-HgR caused seroconversion in most subjects with baseline titers ⩽1:40, including 100% of civilians after one 5 × 108cfu dose, 79% of soldiers after one 5 × 109cfu dose, and 45% of soldiers after one 5 × 108cfu dose. In persons with elevatedbaseline titers, vibriocidal antibody seroconversion is not a sensitive measure of whether vaccine has boosted intestinal immunity; for such subjects,other measurements must be used. Study regimens in endemic areas should use a single 5 × 109cfu dose.